HIGHLIGHTS
- who: European metropolitan region and collaborators from the Institute of Neuropathology, University of Zurich, Zurich, Switzerland have published the article: Journal Pre-proof, in the Journal: (JOURNAL) of 16/08/2022
- what: Apart from assessing the underlying cumulative incidence, the authors aimed to build a foundation for the subsequent identification of sequelae in the clinically well characterized hospital patients. The authors aimed to assess the extent of a bias posed by patients with severe COVID-19, hospitalized at the USZ for this reason. The authors aimed to further depict the evolution of seroprevalence in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.